Life expectancy and cause of death in males and females with Fabry disease: Findings from the Fabry Registry
- 1 November 2009
- journal article
- research article
- Published by Elsevier in Genetics in Medicine
- Vol. 11 (11), 790-796
- https://doi.org/10.1097/gim.0b013e3181bb05bb
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome SurveyJournal of Medical Genetics, 2009
- Agalsidase Alfa and Kidney Dysfunction in Fabry DiseaseJournal of the American Society of Nephrology, 2009
- Myofilament Degradation and Dysfunction of Human Cardiomyocytes in Fabry DiseaseThe American Journal of Pathology, 2008
- Effects of enzyme replacement therapy on the cardiomyopathy of Anderson Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfaHeart, 2008
- Females with Fabry disease frequently have major organ involvement: Lessons from the Fabry RegistryMolecular Genetics and Metabolism, 2007
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- The early clinical phenotype of Fabry disease: a study on 35 European children and adolescentsEuropean Journal of Pediatrics, 2003
- Inflammation and cardiovascular risk in dialysis patientsKidney International, 2002
- Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier femalesJournal of Medical Genetics, 2001
- Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous malesJournal of Medical Genetics, 2001